Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01031082
Other study ID # 112135
Secondary ID
Status Completed
Phase N/A
First received December 10, 2009
Last updated May 20, 2010
Start date May 2009
Est. completion date May 2010

Study information

Verified date May 2010
Source GlaxoSmithKline
Contact n/a
Is FDA regulated No
Health authority South Africa: Medicines Control Council
Study type Observational

Clinical Trial Summary

The purpose of this study is to identify and characterize the bacteria causing acute otitis media episode in HIV-positive and HIV-negative children (>=3 months to <5 years) in South Africa. Middle ear fluid sampling either by tympanocentesis or by careful sampling of spontaneous otorrhoea will be done; nasopharyngeal aspirate and urine sample will also be collected from the subjects.


Recruitment information / eligibility

Status Completed
Enrollment 265
Est. completion date May 2010
Est. primary completion date May 2010
Accepts healthy volunteers No
Gender Both
Age group 3 Months to 5 Years
Eligibility Inclusion Criteria:

Inclusion criteria for all subjects:

- Age: >= 3 months and < 5 years at the time of enrolment.

- Signs, symptoms, and conditions:

- One of the functional or general signs of otalgia,, conjunctivitis, fever and either

- Paradise's criteria or

- Spontaneous otorrhoea of less than 24 hours.

- Subject will be included as a treatment failure case.

- Written informed consent obtained from parent or guardian prior to study start.

Inclusion criteria for HIV-positive subjects:

- Documented HIV-positive status as given in subject's medical records. or

- Subjects referred from paediatric HIV clinic.

Inclusion criteria for HIV-negative subjects (including presumed negative children)

- Children who have been tested HIV-negative.

- Children whose mothers volunteer to have tested HIV-negative whilst pregnant with the index case and the child is free to any World Health Organization Grade II stigmata of HIV/acquired immunodeficiency syndrome.

- Children who do not fulfil the World Health Organization staging for HIV infection / immunosuppression.

Exclusion Criteria:

- Hospitalised during the diagnosis of acute otitis media or during treatment.

- Otitis externa or otitis media with effusion.

- Presence of a transtympanic aerator.

- Systemic antibiotic treatment received for a disease other than acute otitis media in the 72 hours prior to enrolment.

- Receiving antimicrobial prophylaxis for recurrent acute otitis media but excluding cotrimoxazole or isoniazid prophylaxis in HIV exposed children.

- Provision of antibiotic by paediatrician/ENT specialist at the enrolment visit prior to the sampling of the middle ear fluid or spontaneous Otorrhoea.

- Children on antibiotics for acute otitis media who are clinically improving.

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Procedure:
Middle ear fluid, nasopharyngeal aspirate and urine sample.
Middle ear fluid, nasopharyngeal aspirate and urine sample collection.

Locations

Country Name City State
South Africa GSK Investigational Site Soweto Gauteng

Sponsors (1)

Lead Sponsor Collaborator
GlaxoSmithKline

Country where clinical trial is conducted

South Africa, 

Outcome

Type Measure Description Time frame Safety issue
Primary Occurrence of bacterial pathogens isolated from middle ear fluid samples in HIV-positive and HIV-negative subjects. No
Secondary Occurrence of bacterial serotypes. No
Secondary Antimicrobial susceptibility of different bacteria isolated from middle ear fluid samples as assessed by standard microbiological techniques. No
Secondary Occurrence of treatment failure of acute otitis media and of recurrent acute otitis media. No
Secondary Occurrence of spontaneous otorrhoea. No
Secondary Occurrence of bacteria in acute otitis media cases with treatment failure and in new acute otitis media cases without treatment therapy. No
Secondary Occurrence of bacteria in acute otitis media cases vaccinated with a pneumococcal vaccine. No
Secondary Frequency of concurrent respiratory viral infection coinciding with the episode of acute otitis media. No
Secondary The comparison of above endpoints in HIV-positive and HIV-negative subjects. No
See also
  Status Clinical Trial Phase
Completed NCT02092454 - Study to Assess the Safety and Efficacy of Benzocaine for Pain Relief in Children Presenting With Acute Otitis Media Phase 2
Completed NCT01202578 - Evaluation of the Tympanostomy Tube Delivery System Phase 2/Phase 3
Withdrawn NCT00502450 - Is There Hearing Loss After Acute Mastoiditis N/A
Completed NCT04296448 - Evaluation of Cellphone Based Otoscopy in Pediatric Patients N/A
Terminated NCT05651633 - Analgesic Ear Drops for Children With Acute Otitis Media Phase 3
Completed NCT01941381 - Does Tympanometry Predict Antibiotic Usage in Acute Otitis Media?
Completed NCT02345447 - Herbal-Based Medication vs. Placebo in Preventing Acute Otitis Media in Children at High Risk of Recurrence Phase 3
Recruiting NCT01214538 - Assessment of the Natural Antibody Response to Pneumococcal Surface Proteins During Acute Otitis Media in Children N/A
Completed NCT03614117 - Effect of a New Probiotic Strain on Recurrent Acute Otitis Media in Children (PROMAR) N/A
Recruiting NCT06027593 - Using Electronically Derived Automated Reports of Appropriate Antibiotic Use to Inform Stewardship Interventions N/A
Completed NCT02918773 - Pediatric Emergency Department Smartphone Otoscope Study (PED-Oto) N/A
Completed NCT02567747 - Vaccination Impact Against Pneumococcal Disease on Acute Otitis Media Morbidity in Colombian Children < 5 Years of Age
Completed NCT02935374 - Effect of Antimicrobial Treatment of Acute Otitis Media on the Intestinal Microbiome in Children Phase 4
Completed NCT02567825 - Efficacy of Tympanostomy Tubes for Children With Recurrent Acute Otitis Media N/A
Completed NCT02037893 - Four Arm Safety & Efficacy With Antipyrine and Benzocaine Otic Solution in Children With Acute Otitis Media Phase 2
Completed NCT00578773 - A Phase II Study of an Otic Formulation in Treating Peri-Operative Tube Otorrhea Phase 2
Completed NCT00377260 - Acute Otitis Media (AOM) Therapy Trial in Young Children Phase 4
Completed NCT00645112 - A Comparison of Safety and Efficacy of Cefdinir Oral Suspension Versus Azithromycin in Pediatric Subjects With Acute Otitis Media Phase 4
Completed NCT00368823 - A Trial of Point of Care Information in Ambulatory Pediatrics Phase 3
Completed NCT01272999 - Impact of Prevnar 13 on Ear Infections in Children